Phosphorylation of Runx1 at Ser249, Ser266, and Ser276 is dispensable for bone marrow hematopoiesis and thymocyte differentiation

Biochemical and Biophysical Research Communications

Volumn 368, Issue 3, 2008, Pages 536-542

  Tachibana, Masashi ^a,b   Tezuka, Chieko ^a   Muroi, Sawako ^a,c   Nishimoto, Sogo ^a   Katsumoto, Takuo ^d   Nakajima, Atsushi ^b   Kitabayashi, Issay ^d   Taniuchi, Ichiro ^a,c  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Hematopoiesis; Knock in mutagenesis; Lymphocyte differentiation; Phosphorylation; Post translational modifications; Runx1; Transcription factor

Indexed keywords

SERINE; TRANSCRIPTION FACTOR RUNX1;

AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE CONTROL; GENE MUTATION; GENE TARGETING; HEMATOPOIESIS; MOUSE STRAIN; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; THYMOCYTE; TRANSACTIVATION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 2 SUBUNIT; HEMATOPOIESIS; LYMPHOCYTES; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; SERINE; THYMUS GLAND;

MAMMALIA; MUS;

EID: 39749140880     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.01.124     Document Type: Article

References (21)

1. van Wijnen A.J., Stein G.S., Gergen J.P., Groner Y., Hiebert S.W., Ito Y., Liu P., Neil J.C., Ohki M., and Speck N. Nomenclature for Runt-related (RUNX) proteins. Oncogene 23 (2004) 4209-4210
2. de Bruijn M.F., and Speck N.A. Core-binding factors in hematopoiesis and immune function. Oncogene 23 (2004) 4238-4248
3. Lee J., Ahnn J., and Bae S.C. Homologs of RUNX and CBF beta/PEBP2 beta in C. elegans. Oncogene 23 (2004) 4346-4352
4. Komori T. Runx2, a multifunctional transcription factor in skeletal development. J. Cell. Biochem. 87 (2002) 1-8
5. Canon J., and Banerjee U. Runt and Lozenge function in Drosophila development. Semin. Cell Dev. Biol. 11 (2000) 327-336
6. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., and Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84 (1996) 321-330
7. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., and Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93 (1996) 3444-3449
8. Look A.T. Oncogenic transcription factors in the human acute leukemias. Science 278 (1997) 1059-1064
9. Osato M., Asou N., Abdalla E., Hoshino K., Yamasaki H., Okubo T., Suzushima H., Takatsuki K., Kanno T., Shigesada K., and Ito Y. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 93 (1999) 1817-1824
10. Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., and Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88 (1991) 10431-10434
11. Aikawa Y., Nguyen L.A., Isono K., Takakura N., Tagata Y., Schmitz M.L., Koseki H., and Kitabayashi I. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J. 25 (2006) 3955-3965
12. Tanaka T., Kurokawa M., Ueki K., Tanaka K., Imai Y., Mitani K., Okazaki K., Sagata N., Yazaki Y., Shibata Y., Kadowaki T., and Hirai H. The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol. Cell. Biol. 16 (1996) 3967-3979
13. Zhang Y., Biggs J.R., and Kraft A.S. Phorbol ester treatment of K562 cells regulates the transcriptional activity of AML1c through phosphorylation. J. Biol. Chem. 279 (2004) 53116-53125
14. Aho T.L., Sandholm J., Peltola K.J., Ito Y., and Koskinen P.J. Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity. BMC Cell. Biol. 7 (2006) 21
15. Taniuchi I., Osato M., Egawa T., Sunshine M.J., Bae S.C., Komori T., Ito Y., and Littman D.R. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111 (2002) 621-633
16. Egawa T., Tillman R.E., Naoe Y., Taniuchi I., and Littman D.R. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells. J. Exp. Med. 204 (2007) 1945-1957
17. Oestreich K.J., Cobb R.M., Pierce S., Chen J., Ferrier P., and Oltz E.M. Regulation of TCRbeta gene assembly by a promoter/enhancer holocomplex. Immunity 24 (2006) 381-391
18. Ichikawa M., Asai T., Saito T., Seo S., Yamazaki I., Yamagata T., Mitani K., Chiba S., Ogawa S., Kurokawa M., and Hirai H. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10 (2004) 299-304
19. Alberola-Ila J., and Hernandez-Hoyos G. The Ras/MAPK cascade and the control of positive selection. Immunol. Rev. 191 (2003) 79-96
20. Egawa T., Eberl G., Taniuchi I., Benlagha K., Geissmann F., Hennighausen L., Bendelac A., and Littman D.R. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22 (2005) 705-716
21. Zhang L., Fried F.B., Guo H., and Friedman A.D. Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on three sites increases trans-activation potency and stimulates cell proliferation. Blood (2007)